Phase 1/2 evaluation of intrathecal 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick disease type C1

20165 citationsJournal Article

Authors

Good health and well-being

Published in: Molecular Genetics and Metabolism

Volume 117, Issue 2, pp. S97-S97

Field-Weighted Citation Impact: 0.77